Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2000
12/05/2000CA2146150C Dna encoding a prostaglandin receptor, a host cell transformed therewith and an expression product thereof
12/05/2000CA2136822C Thio-substituted cyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
12/05/2000CA2098921C Angiogenic peptides
12/04/2000WO2000075103A1 SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES AS AGONISTS TO HUMAN PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) $g(a)
12/04/2000CA2310873A1 New arylpiperazinylalkyl-3 (2h)-pyridazinones
11/2000
11/30/2000WO2000072021A2 Cancer associated antigens and uses therefor
11/30/2000WO2000072008A2 Identification of novel mechanisms of drug resistance
11/30/2000WO2000071741A2 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000WO2000071723A2 Methods for regulating protein conformation using molecular chaperones
11/30/2000WO2000071720A1 Il-1 eta dna and polypeptides
11/30/2000WO2000071713A1 Vascular endothelial growth factor variants
11/30/2000WO2000071679A2 Human oxidoreductase proteins
11/30/2000WO2000071571A2 Fap-activated anti-tumor compounds
11/30/2000WO2000071557A1 13-methyl-erythromycin derivatives
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071543A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000WO2000071538A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
11/30/2000WO2000071535A1 INDOLE-TYPE DERIVATIVES AS INHIBITORS OF p38 KINASE
11/30/2000WO2000071523A1 Antibiotic prodrugs
11/30/2000WO2000071522A1 Benzimidazole derivatives and their use as methionyl t-rna synthetase inhibitors
11/30/2000WO2000071520A2 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000WO2000071518A2 Heterocyclic analgesic compounds and their use
11/30/2000WO2000071517A1 Phenoxypropylamine compounds
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071512A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071511A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071510A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071509A1 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071508A2 INHIBITORS OF FACTOR Xa
11/30/2000WO2000071506A2 Naphthalene ureas as glucose uptake enhancers
11/30/2000WO2000071161A1 Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferative drugs
11/30/2000WO2000071148A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000WO2000071146A2 Glutathione reductase for therapy and prophylaxis of aids
11/30/2000WO2000071144A1 Prolyl endopeptidase inhibitor
11/30/2000WO2000071135A1 Anti-tumor comprising boroproline compounds
11/30/2000WO2000071132A1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
11/30/2000WO2000071129A1 Pyrrolotriazine inhibitors of kinases
11/30/2000WO2000071114A1 Salts of cis-[4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate]
11/30/2000WO2000071104A2 Use of bisphosphonic acids for treating angiogenesis
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000071094A1 Ascorbic acid derivative composition for increasing cell renewal rate
11/30/2000WO2000071093A1 Niacinamide compositions with reduced tack
11/30/2000WO2000047615A3 Proteins related to neuronal regeneration and uses thereof
11/30/2000WO2000047559A3 5-ht1f agonists
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000044404A3 Methods for inhibiting brain tumor growth by using selected integrin antagonists
11/30/2000WO2000043408A3 Steroid sulfatase inhibitors and methods for making and using the same
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000041692A3 Compositions having improved stability
11/30/2000WO2000038716A9 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/30/2000WO2000037096A3 Treatment of hepatitis c virus infections with interleukin-10
11/30/2000WO2000035434A3 Compositions and methods for the treatment of anorectal disorders
11/30/2000WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/30/2000WO2000028019A3 Antisense oligomer
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000WO2000021572A3 Hydrogels and water soluble polymeric carriers for drug delivery
11/30/2000WO2000018918A3 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000DE19924401A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000CA2716369A1 Phenoxypropylamine compounds
11/30/2000CA2684016A1 Methods and compounds for inhibiting amyloid deposits
11/30/2000CA2382751A1 Inhibitors of factor xa
11/30/2000CA2375543A1 Salts of cis-¬4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexan-1-carboxylate|
11/30/2000CA2375066A1 Antibiotic prodrugs
11/30/2000CA2374947A1 Inhibitors of factor xa
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374918A1 Identification of novel mechanisms of drug resistance
11/30/2000CA2374820A1 Inhibitors of factor xa
11/30/2000CA2374793A1 Inhibitors of factor xa
11/30/2000CA2374714A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000CA2374650A1 Inhibitors of factor xa
11/30/2000CA2374432A1 Dna encoding a human subunit of the 5-ht3 serotonin receptor
11/30/2000CA2374413A1 Human oxidoreductase proteins
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2374225A1 Naphthalene ureas as glucose uptake enhancers
11/30/2000CA2374049A1 Use of bisphosphonic acids for treating angiogenesis
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2373822A1 Vascular endothelial growth factor variants
11/30/2000CA2373789A1 Aryl substituted alkylamines capable of activating nicotinic cholinergic receptors
11/30/2000CA2373643A1 Anti-tumor comprising boroproline compounds
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372887A1 Heterocyclic analgesic compounds and their use
11/30/2000CA2372567A1 Indole-type derivatives as inhibitors of p38 kinase
11/30/2000CA2371920A1 Niacinamide compositions with reduced tack
11/30/2000CA2369933A1 Fap-activated anti-tumor compounds
11/29/2000EP1055668A1 New 4-arylpiperidine derivatives for the treatment of pruritus
11/29/2000EP1055366A1 Use of transgenic mice lacking jun-b expression in the myeloid lineage
11/29/2000EP1054998A1 Transglutaminase linkage of agents to tissue
11/29/2000EP1054994A2 Fermentative preparation process for cytostatics and crystal forms thereof
11/29/2000EP1054993A1 PROCESS FOR THE OBTAINING OF HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054953A1 NOVEL pgsA
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054903A1 Fishboy, a g-protein coupled receptor
11/29/2000EP1054899A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON $g(b)-CATENIN, AND THE PRODUCTION AND USE THEREOF
1 ... 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 ... 1564